🇫🇷 France Country × Condition
epilepsy Clinical Trials in France
Active clinical trials for epilepsy with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇫🇷 France
Active Trials in France (5)
NCT04451278
Recruiting
RESting-state Functional MRI for Prediction of Post-surgical Prognosis In Pediatric Drug-Resistant Epilepsy
Enrollment
200 pts
Country
🇫🇷 France
Fondation Ophtalmologique Adolphe d...
View Trial → NCT07075380
Recruiting
National Survey on Physical and Sports Activity of Adults With Epilepsy
Enrollment
400 pts
Country
🇫🇷 France
Fondation Ophtalmologique Adolphe d...
View Trial → NCT05527093
Recruiting
Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy
Enrollment
20 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial → NCT06202196
Recruiting
Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy
Enrollment
74 pts
Country
🇫🇷 France
University Hospital, Montpellier
View Trial → NCT05126914
Recruiting
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
Enrollment
1,000 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial → Frequently Asked Questions
How many epilepsy clinical trials are active in France?
There are currently 5 active clinical trials for epilepsy with sites in France, of which 5 are actively recruiting patients.
How can I join a epilepsy clinical trial in France?
To join a epilepsy clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are epilepsy trials in France?
Active epilepsy trials in France span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology